应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NUVL Nuvalent, Inc.
未开盘 11-04 16:00:00 EST
89.53
+0.31
+0.35%
盘后
89.53
+0.00
0.00%
17:24 EST
最高
90.04
最低
87.30
成交量
48.66万
今开
88.63
昨收
89.22
日振幅
3.07%
总市值
63.09亿
流通市值
43.66亿
总股本
7,047万
成交额
4,335万
换手率
1.00%
流通股本
4,876万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Nuvalent, Inc.跌5.08% 股价跌破100美元大关
市场透视 · 10-23
Nuvalent, Inc.跌5.08% 股价跌破100美元大关
Nuvalent, Inc.跌1.46% 股价跌破100美元大关
市场透视 · 10-10
Nuvalent, Inc.跌1.46% 股价跌破100美元大关
Nuvalent, Inc.跌2.25% 股价跌破100美元大关
市场透视 · 10-01
Nuvalent, Inc.跌2.25% 股价跌破100美元大关
Nuvalent, Inc.涨1.58% 股价突破100美元大关
市场透视 · 09-30
Nuvalent, Inc.涨1.58% 股价突破100美元大关
Nuvalent, Inc.跌1.27% 股价跌破100美元大关
市场透视 · 09-28
Nuvalent, Inc.跌1.27% 股价跌破100美元大关
Nuvalent, Inc.盘中异动 股价大跌5.03%
市场透视 · 09-23
Nuvalent, Inc.盘中异动 股价大跌5.03%
ESMO 2024|挑战“地狱难度”,冒险家与biotech精神
蓝鲸财经 · 09-23
ESMO 2024|挑战“地狱难度”,冒险家与biotech精神
Nuvalent, Inc.盘中异动 股价大涨5.04%报107.80美元
市场透视 · 09-20
Nuvalent, Inc.盘中异动 股价大涨5.04%报107.80美元
Nuvalent, Inc.盘中异动 大幅下挫5.05%报106.51美元
市场透视 · 09-17
Nuvalent, Inc.盘中异动 大幅下挫5.05%报106.51美元
异动解读 | 股票增发引发估值担忧 Nuvalent股价盘前大跌5%
异动解读 · 09-17
异动解读 | 股票增发引发估值担忧 Nuvalent股价盘前大跌5%
BUZZ-生物制药公司 Nuvalent 在增发 5 亿美元股票后业绩下滑
Reuters · 09-17
BUZZ-生物制药公司 Nuvalent 在增发 5 亿美元股票后业绩下滑
BUZZ--美国股票走势-Charles Schwab、CACI International、Icahn Enterprises
Reuters · 09-17
BUZZ--美国股票走势-Charles Schwab、CACI International、Icahn Enterprises
BUZZ--美国股票走势-博士伦、美国铝业、加密股票
Reuters · 09-16
BUZZ--美国股票走势-博士伦、美国铝业、加密股票
BUZZ-因癌症治疗数据前景看好,券商上调 PT 值,Nuvalent 公司股价上涨
Reuters · 09-16
BUZZ-因癌症治疗数据前景看好,券商上调 PT 值,Nuvalent 公司股价上涨
BUZZ-Nuvalent 在券商上调 PT 后上涨
Reuters · 09-16
BUZZ-Nuvalent 在券商上调 PT 后上涨
美国研究综述-Avalonbay Communities、Elf Beauty、Evercore
Reuters · 09-16
美国研究综述-Avalonbay Communities、Elf Beauty、Evercore
美国研究综述-Array Technologies、Hess、Lennar
Reuters · 09-04
美国研究综述-Array Technologies、Hess、Lennar
美国研究综述-Array Technologies、Hess、Lennar
Reuters · 09-04
美国研究综述-Array Technologies、Hess、Lennar
Nuvalent, Inc.盘中异动 急速拉升5.35%
市场透视 · 08-24
Nuvalent, Inc.盘中异动 急速拉升5.35%
Nuvalent, Inc.盘中异动 快速拉升5.25%报80.31美元
市场透视 · 08-22
Nuvalent, Inc.盘中异动 快速拉升5.25%报80.31美元
加载更多
公司概况
公司名称:
Nuvalent, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nuvalent, Inc.于2017年1月25日根据特拉华州法律注册成立。他们是一家临床前阶段的生物制药公司,专注于为癌症患者创造精准的靶向治疗。他们的发现工作集中在激酶的小分子抑制剂上,这是一类可以在癌症生长和增殖中发挥核心作用的细胞靶标。特别是,他们专注于“临床证明”的激酶靶点,并且这些药物已经证明了足够的临床疗效和安全性数据,可以得到美国食品和药物管理局的批准并在临床环境中建立和使用。
发行价格:
--
{"stockData":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":89.53,"timestamp":1730754000000,"preClose":89.22,"halted":0,"volume":486583,"hourTrading":{"tag":"盘后","latestPrice":89.53,"preClose":89.53,"latestTime":"17:24 EST","volume":16623,"amount":1488261.44,"timestamp":1730759060434},"delay":0,"floatShares":48761786,"shares":70470000,"eps":-2.798883,"marketStatus":"未开盘","marketStatusCode":0,"change":0.31,"latestTime":"11-04 16:00:00 EST","open":88.63,"high":90.04,"low":87.2994,"amount":43351319.25471,"amplitude":0.030717,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.798883,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"listingDate":1627531200000,"adjPreClose":89.22,"preHourTrading":{"tag":"盘前","latestPrice":86.77,"preClose":89.22,"latestTime":"09:19 EST","volume":5,"amount":433.84999999999997,"timestamp":1730729946311},"postHourTrading":{"tag":"盘后","latestPrice":89.53,"preClose":89.53,"latestTime":"17:24 EST","volume":16623,"amount":1488261.44,"timestamp":1730759060434},"volumeRatio":0.775108,"impliedVol":0.5249,"impliedVolPercentile":0.2869},"requestUrl":"/m/hq/s/NUVL","defaultTab":"news","newsList":[{"id":"2477042538","title":"Nuvalent, Inc.跌5.08% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2477042538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477042538?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690271,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分,Nuvalent, Inc.股票出现异动,股价大幅下跌5.08%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Dbv Technologies涨幅较大,Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为842.55%、474.19%、266.63%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Okyo Pharma Ltd Com Npv ,振幅分别为27.06%、17.26%、13.56%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311195bd428c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311195bd428c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2474443547","title":"Nuvalent, Inc.跌1.46% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2474443547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474443547?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:57","pubTimestamp":1728568675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时57分,Nuvalent, Inc.股票出现异动,股价快速下挫1.46%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为210.06%、128.20%、104.09%,振幅较大的相关个股有Genenta Science Spa、Tevogen Bio Holdings Inc.、Gri Bio, Inc.,振幅分别为25.48%、20.40%、18.60%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021575598e3bbbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021575598e3bbbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2472937770","title":"Nuvalent, Inc.跌2.25% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2472937770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472937770?lang=zh_cn&edition=full","pubTime":"2024-10-01 23:02","pubTimestamp":1727794969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日23时02分,Nuvalent, Inc.股票出现异动,股价快速下跌2.25%。截至发稿,该股报100.00美元/股,成交量17.1446万股,换手率0.24%,振幅2.14%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012302499719db98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012302499719db98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2471857953","title":"Nuvalent, Inc.涨1.58% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2471857953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471857953?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:48","pubTimestamp":1727704136,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时48分,Nuvalent, Inc.股票出现异动,股价快速上涨1.58%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Prime Medicine, Inc.、Kezar Life Sciences, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大,Aditxt, Inc.、Onconetix, Inc.、Seelos Therapeutics, Inc.较为活跃,换手率分别为56.35%、22.99%、22.59%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Cingulate Inc C/Wts 10/12/2026 、Plus Therapeutics, Inc.,振幅分别为32.54%、31.55%、28.10%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302148569719d9a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302148569719d9a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2470805378","title":"Nuvalent, Inc.跌1.27% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2470805378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470805378?lang=zh_cn&edition=full","pubTime":"2024-09-28 03:04","pubTimestamp":1727463885,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日03时04分,Nuvalent, Inc.股票出现波动,股价大幅下跌1.27%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Onconetix, Inc.、Seelos Therapeutics, Inc.、Aditxt, Inc.较为活跃,换手率分别为4459.67%、277.36%、151.98%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Estrella Immunopharma, Inc.,振幅分别为167.75%、69.81%、65.94%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092803044598e39761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092803044598e39761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2469711145","title":"Nuvalent, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469711145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469711145?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:03","pubTimestamp":1727103798,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时03分,Nuvalent, Inc.股票出现波动,股价大幅下挫5.03%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为1.01%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为250.66%、46.15%、43.90%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Black Diamond Therapeutics, Inc.,振幅分别为42.83%、42.78%、25.84%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230319a1dbf055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230319a1dbf055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2469366701","title":"ESMO 2024|挑战“地狱难度”,冒险家与biotech精神","url":"https://stock-news.laohu8.com/highlight/detail?id=2469366701","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469366701?lang=zh_cn&edition=full","pubTime":"2024-09-23 09:39","pubTimestamp":1727055553,"startTime":"0","endTime":"0","summary":"年初的ASCO大会上,洛拉替尼的CROWN研究随访数据引起了广泛关注。然而,洛拉替尼可能没有预见到,尽管其数据表现卓越,但并未能完全阻止竞争者的涌现;相反,潜在的挑战者迅速崛起。在9月份的ESMO大会上,新型ALK抑制剂NVL-655公布了其疗效和安全性的最新数据。这也许正是我们常说的biotech精神,也是国内生物技术企业需要学习和借鉴的。在此次ESMO大会上,Nuvalent展示了其人体1期试验的更新数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/240667","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4211","OS","NUVL","BK4097","BK4139","BK4539","BK4195","PFS"],"gpt_icon":0},{"id":"2468857986","title":"Nuvalent, Inc.盘中异动 股价大涨5.04%报107.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468857986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468857986?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:02","pubTimestamp":1726768967,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时02分,Nuvalent, Inc.股票出现波动,股价大幅拉升5.04%。截至发稿,该股报107.80美元/股,成交量44.959万股,换手率0.64%,振幅5.00%。Nuvalent, Inc.股票所在的生物技术行业中,整体涨幅为1.52%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920020248a1db39ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920020248a1db39ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2468235237","title":"Nuvalent, Inc.盘中异动 大幅下挫5.05%报106.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468235237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468235237?lang=zh_cn&edition=full","pubTime":"2024-09-17 21:31","pubTimestamp":1726579868,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日21时31分,Nuvalent, Inc.股票出现波动,股价大幅下挫5.05%。截至发稿,该股报106.51美元/股,成交量17.9081万股,换手率0.28%,振幅2.64%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.58%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917213108956ab36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917213108956ab36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"1123397215","title":"异动解读 | 股票增发引发估值担忧 Nuvalent股价盘前大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123397215","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123397215?lang=zh_cn&edition=full","pubTime":"2024-09-17 20:30","pubTimestamp":1726576223,"startTime":"0","endTime":"0","summary":"生物制药公司Nuvalent周一晚间宣布以100美元/股的价格增发500万股股票,募资5亿美元。这一增发价格较上一次交易价112.17美元折价10.8%,引发了市场对公司估值的担忧。\n\n消息公布后,Nuvalent股价周二盘前大跌5.01%,至108.89美元。此前该股周一曾大涨28.2%,创下历史新高,主要是因公司公布了其癌症疗法临床试验乐观数据。\n\n分析人士指出,虽然增发有助于公司筹集发展资金,但定价过低可能会引发投资者对公司前景的质疑,加上股价已经大涨,出现获利了结行为也在情理之中。目前公司市值约为73亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NUVL"],"gpt_icon":0},{"id":"2468353180","title":"BUZZ-生物制药公司 Nuvalent 在增发 5 亿美元股票后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2468353180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468353180?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:46","pubTimestamp":1726573584,"startTime":"0","endTime":"0","summary":" 9月17日 - ** Nuvalent公司 股价盘前下跌2.9%,至108.89美元。** 生物制药公司周一晚些时候宣布 以 100 美元的价格发行 500 万股,筹资 5 亿美元。** 交易规模从 3.5 亿美元扩大到 5 亿美元,定价比股票最后一次交易折价 10.8** NUVL 公司公布了其癌症疗法 NVL-655 早期研究的乐观数据 后,周一股价大涨 28.2%,收盘价达到 112.17 美元,创下历史新高。** 根据伦敦证券交易所的数据,该公司拥有约 6480 万股已发行股票,市值约为 73 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","IE00BJTD4V19.USD","BK4504","LU0211331839.USD","IE00BHPRN162.USD","BK4516","BK4585","IE00B1XK9C88.USD","LU0215105999.USD","LU1162221912.USD","IE00B775SV38.USD","LU1244550221.USD","IE00BKVL7J92.USD","IE000M9KFDE8.USD","LU1032466523.USD","LU0170899867.USD","LU0971096721.USD","NUVL","BK4588","LU1363072403.SGD","LU0149725797.USD","LU1267930490.SGD","LU","LU0323591593.USD","BK4139","IE00BJTD4N35.SGD","LU0976567544.SGD","LU0882574139.USD","LU0211328371.USD","LU0238689110.USD","LU1496350171.SGD","LU1244550494.USD","LU0310799852.SGD","LU1496350502.SGD","BK4581","LU1064131342.USD","IE00BFXG1179.USD","IE0034235188.USD","LU0267386448.USD","LU0496365809.HKD","LU1668664300.SGD","BK4566","LU1119994496.HKD","BK4550","LU1084165304.USD","LU0211327993.USD","LU0320765489.SGD","LU0070302665.USD","BK4207","LU0256863811.USD"],"gpt_icon":0},{"id":"2468847510","title":"BUZZ--美国股票走势-Charles Schwab、CACI International、Icahn Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=2468847510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468847510?lang=zh_cn&edition=full","pubTime":"2024-09-17 00:07","pubTimestamp":1726502845,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月16日 - 科技股周一拖累了标普500指数和纳斯达克指数,因为在本周晚些时候美联储将做出关键的货币政策决定之前,市场谨慎情绪弥漫,大多数交易商认为借贷成本将大幅下降。美东时间11:31,道琼斯工业平均指数 上涨0.19%,报41,470.55点。标普500指数 下跌0.17%,报5616.5点;纳斯达克综合指数 下跌0.79%,报17544.279点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOS","FDX","CSLR","LSCC","KLXE","NQmain","BLDR","SCHW","YELP","COIN","CACI","ESS","DPZ","EQR","QID","SYF","UDOW","WYNN","CVX","MGM","DOG","IEP","UDR","DJX",".DJI","QLD","ZG","ITOS","REE","SBT",".IXIC","SQQQ","CZR","MNQmain","NUVL","APA","COP","HUT","LVS","ICE","EOG","ALLY","UPST","ZNTL","AVB",".SPX"],"gpt_icon":1},{"id":"2467848578","title":"BUZZ--美国股票走势-博士伦、美国铝业、加密股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2467848578","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467848578?lang=zh_cn&edition=full","pubTime":"2024-09-16 21:21","pubTimestamp":1726492860,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月16日 - 美国主要股指周一开盘涨跌不一,因为在美联储本周晚些时候将做出关键的货币政策决定之前,华尔街开始变得谨慎,大多数交易员认为借贷成本将大幅下调。美东时间9:04,道指电子盘 上涨0.21%,报41513 点。标普500指数小型股 下跌0.08%,报5625.5点;纳斯达克100指数小型股 下跌0.48%,报19436点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUT","CZR","ZG","BLDR","BK4150","BK4515","AVB","LU1153585028.USD","LU1883839398.USD","ESS","IE00B19Z3B42.SGD","LU0980610538.SGD","BK4504","ITOS","CL","UPST","LU2237443382.USD","LVS","NUVL","BLCO","ALLY","AA","LU0868494617.USD","MGM","BK4550","COIN","SG9999001176.USD","LU0081259029.USD","LU0052756011.USD","LU1599440770.SGD","EQR","BK4512","LU0310800965.SGD","LU0130517989.USD","BK4007","RIOT","UDR","LU0323591593.USD","LU2023250504.SGD","FDX","BK4503","ICE","LU1917777945.USD","WYNN","ZNTL","SG9999013999.USD","BK4018"],"gpt_icon":1},{"id":"2467812207","title":"BUZZ-因癌症治疗数据前景看好,券商上调 PT 值,Nuvalent 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467812207","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467812207?lang=zh_cn&edition=full","pubTime":"2024-09-16 20:33","pubTimestamp":1726490014,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) (更新) 9月16日 - ** 疗法开发商Nuvalent 股价盘前上涨22.3%至106.99美元,如果涨势保持,开盘价有望创下历史新高 ** 至少四家券商上调该股的预测价格 ** 该公司上周末在欧洲肿瘤内科学会大会上公布了其实验性癌症疗法NVL-655的最新早期数据** Guggenheim 将该公司的预测价格从 99 美元上调至 105","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","PT","NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2467119688","title":"BUZZ-Nuvalent 在券商上调 PT 后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467119688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467119688?lang=zh_cn&edition=full","pubTime":"2024-09-16 19:48","pubTimestamp":1726487284,"startTime":"0","endTime":"0","summary":" 9月16日 - ** 疗法开发商Nuvalent 股价盘前上涨20%至105美元 ** 至少四家券商上调股票交易价格 ** 该公司上周末在欧洲肿瘤内科学会大会上公布了其实验性癌症疗法NVL-655的最新早期数据** 古根海姆将该公司的预测价格从 99 美元上调至 105 美元,股票评级为 \"买入\";古根海姆称,更新后的数据应能增强投资者对 NVL-655 的信心,使其成为一种潜在的一流疗法;古根海姆还补充说,该疗法还能使全球可寻址市场从约 20 亿美元增长到超过 40 亿美元的长期市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","PT","BK4139","NUVL","BK4166"],"gpt_icon":0},{"id":"2467896852","title":"美国研究综述-Avalonbay Communities、Elf Beauty、Evercore","url":"https://stock-news.laohu8.com/highlight/detail?id=2467896852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467896852?lang=zh_cn&edition=full","pubTime":"2024-09-16 15:19","pubTimestamp":1726471184,"startTime":"0","endTime":"0","summary":" 路透9月16日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括Avalonbay Communities、Elf Beauty 和 Evercore 。要闻 * Avalonbay Communities Inc :摩根大通将目标价从212美元上调至247美元 * Elf Beauty Inc :Piper Sandler将目标价从260美元下调至162美元 * Evercore Inc :CFRA将其目标价从 \"买入 \"下调至 \"持有 * GE Vernova :汇丰银行将目标价从215美元上调至240美元 以下是路透周一报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","TCBI","MSTR","IE0005OL40V9.USD","LU1481011671.HKD","BK4182","LU1064131342.USD","UDR","PGR","EVR","BK4215","BK4588","LU1242518857.USD","IE00BZ1G4Q59.USD","RITM","COOP","EQR","VRE","IE00BJJMRY28.SGD","PFSI","BK4595","ALLY","GEV","BK4211","IE00B4JS1V06.HKD","AMH","LU0742537680.HKD","LU1718418525.SGD","LU1983260115.SGD","IE00BFSS7M15.SGD","RKT","ESS","AVB","RC","BK4023","BK4139","SG9999004303.SGD","NUVL","ELF","LU1481011911.USD","CPT","ELME","LU0053671581.USD","LU1242518931.SGD","LU2355687059.USD","ONIT","BK4183","INVH","BK4228","LU0731783394.SGD"],"gpt_icon":1},{"id":"2464329959","title":"美国研究综述-Array Technologies、Hess、Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2464329959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464329959?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:43","pubTimestamp":1725443007,"startTime":"0","endTime":"0","summary":" 路透9月4日 - 华尔街证券分析师周三调整了对 Array Technologies、Hess 和 Lennar 等几家美国上市公司的评级和目标价。要闻 * Array Technologies Inc :杰富瑞维持 \"买入 \"评级,目标价11美元。* Nextracker Inc :杰富瑞给予 \"持有 \"评级,目标价46美元 * Nuvalent Inc :摩根大通将目标价从90美元上调至100美元 * 西方石油公司 :Susquehanna 将目标价从 81 美元下调至 78 美元 * Onestream Inc :Piper Sandler将目标价从32美元上调至34美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRPT","HASI","STZ","DVN","FANG","FNF","LU0154245673.USD","APA","LU0348723411.USD","GWRE","MITK","BBIO","CTRA","HES","FAF","NUVL","ABNB","ENPH","CDP","ORKA","LU1992135472.HKD","BKNG","LRMR","FSLR","FLNC","LU1093756168.USD","AFCG","LU0082616367.USD","NXT","GTLB","LU0823414478.USD","OS","LU0130102774.USD","EOG","GEV","MGY","BK4519","ASAN","LEN","ARRY","COP","LU","CASY","LU0053666078.USD","ATHA","AMRC","LU1988902786.USD","MRO","ASND"],"gpt_icon":1},{"id":"2464299513","title":"美国研究综述-Array Technologies、Hess、Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2464299513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464299513?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:43","pubTimestamp":1725443007,"startTime":"0","endTime":"0","summary":" 路透9月4日 - 华尔街证券分析师周三调整了对 Array Technologies、Hess 和 Lennar 等几家美国上市公司的评级和目标价。要闻 * Array Technologies Inc :杰富瑞维持 \"买入 \"评级,目标价11美元。* Nextracker Inc :杰富瑞给予 \"持有 \"评级,目标价46美元 * Nuvalent Inc :摩根大通将目标价从90美元上调至100美元 * 西方石油公司 :Susquehanna 将目标价从 81 美元下调至 78 美元 * Onestream Inc :Piper Sandler将目标价从32美元上调至34美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","CTRA","BBIO","OXY","HASI","LU0082616367.USD","LU1992135472.HKD","MITK","HES","STZ","COP","AFCG","BK4519","FNF","LEN","APA","LU","FLNC","NXT","ENPH","FAF","FANG","ASND","LU0053666078.USD","LRMR","GEV","ASAN","LU1988902786.USD","GWRE","EOG","GTLB","AMRC","ABNB","MGY","ARRY","ATHA","CASY","MRO","LU0348723411.USD","DVN","FSLR","LU0823414478.USD","NUVL","ORKA","LU0130102774.USD","CDP","LU0154245673.USD","LU1093756168.USD","BKNG","FRPT"],"gpt_icon":0},{"id":"2461453005","title":"Nuvalent, Inc.盘中异动 急速拉升5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461453005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461453005?lang=zh_cn&edition=full","pubTime":"2024-08-24 01:44","pubTimestamp":1724435046,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日01时44分,Nuvalent, Inc.股票出现波动,股价快速上涨5.35%。截至发稿,该股报87.44美元/股,成交量19.6557万股,换手率0.30%,振幅5.39%。Nuvalent, Inc.股票所在的生物技术行业中,整体涨幅为0.83%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824014406ab5f7134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824014406ab5f7134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2461876288","title":"Nuvalent, Inc.盘中异动 快速拉升5.25%报80.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461876288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461876288?lang=zh_cn&edition=full","pubTime":"2024-08-22 00:53","pubTimestamp":1724259220,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日00时53分,Nuvalent, Inc.股票出现异动,股价大幅上涨5.25%。截至发稿,该股报80.31美元/股,成交量13.0634万股,换手率0.20%,振幅5.40%。Nuvalent, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。Nuvalent, Inc.公司简介:Nuvalent Inc是一家临床阶段的生物制药公司,专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082200534097199811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082200534097199811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.nuvalent.com","stockEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.1385},{"period":"3month","weight":0.2195},{"period":"6month","weight":0.2682},{"period":"1year","weight":0.6189},{"period":"ytd","weight":0.2124}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuvalent, Inc.于2017年1月25日根据特拉华州法律注册成立。他们是一家临床前阶段的生物制药公司,专注于为癌症患者创造精准的靶向治疗。他们的发现工作集中在激酶的小分子抑制剂上,这是一类可以在癌症生长和增殖中发挥核心作用的细胞靶标。特别是,他们专注于“临床证明”的激酶靶点,并且这些药物已经证明了足够的临床疗效和安全性数据,可以得到美国食品和药物管理局的批准并在临床环境中建立和使用。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.084747},{"month":2,"riseRate":1,"avgChangeRate":0.076205},{"month":3,"riseRate":0,"avgChangeRate":-0.105637},{"month":4,"riseRate":0.333333,"avgChangeRate":0.004859},{"month":5,"riseRate":0.333333,"avgChangeRate":0.001101},{"month":6,"riseRate":1,"avgChangeRate":0.229396},{"month":7,"riseRate":1,"avgChangeRate":0.110591},{"month":8,"riseRate":0.75,"avgChangeRate":0.277791},{"month":9,"riseRate":0.75,"avgChangeRate":-0.004719},{"month":10,"riseRate":0.75,"avgChangeRate":0.22961},{"month":11,"riseRate":0.5,"avgChangeRate":0.014263},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.025299}],"exchange":"NASDAQ","name":"Nuvalent, Inc.","nameEN":"Nuvalent, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuvalent, Inc.,NUVL,Nuvalent, Inc.股票,Nuvalent, Inc.股票老虎,Nuvalent, Inc.股票老虎国际,Nuvalent, Inc.行情,Nuvalent, Inc.股票行情,Nuvalent, Inc.股价,Nuvalent, Inc.股市,Nuvalent, Inc.股票价格,Nuvalent, Inc.股票交易,Nuvalent, Inc.股票购买,Nuvalent, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}